You can buy or sell Flex Pharma and other stocks, options, ETFs, and crypto commission-free!
Flex Pharma, Inc. operates as a clinical-stage biotechnology company. It operates through the Consumer Operations and Drug Development segments. Read More The Consumer Operations segment includes HOTSHOT product and consumer operations. The Drug Development segment engages in the development of innovative and proprietary drug products to treat muscle cramps and spasms associated with severe neurological conditions. The company was founded by Rod MacKinnon, Bruce Bean, Christoph Westphal, Rich Aldrich, Michelle Dipp, and Jennifer M. Cermak in February 2014 and is headquartered in Boston, MA.
52 Week High
52 Week Low
Markets InsiderFeb 26
SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of Flex Pharma, Inc. - FLKS
NEW YORK, Feb. 26, 2019 /PRNewswire/ -- Juan Monteverde, founder and managing partner at Monteverde & Associates PC, a national securities firm headquartered at the Empire State Building in New York City, is investigating the Board of Directors of Flex Pharma, Inc. ("FLKS" or the "Company") (NasdaqCM: FLKS) related to the sale of the company to Salarius Pharmaceuticals, LLC. Under the terms of the proposed transaction, FLKS stockholders will own 19.9% of the combined company upon completion of the transacti...
Expected May 1, Pre-Market